Share price
ATLN SIX Swiss Exchange
| At 17:30:59 CET 27/01/2012 | |
| CHF 35,65 |  |
| -0,19 (-0,53%) | |
Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
Actelion has subsidaries in 29 countries, covering all major pharmaceutical markets worldwide
ATLN SIX Swiss Exchange
| At 17:30:59 CET 27/01/2012 | |
| CHF 35,65 | |
| -0,19 (-0,53%) | |
